切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2017, Vol. 14 ›› Issue (10) : 743 -748. doi: 10.3877/cma.j.issn.1672-6448.2017.10.006

所属专题: 妇产科超声影像学 乳腺超声 文献

浅表器官超声影像学

超声与正电子发射型计算机断层成像技术在乳腺癌诊断及淋巴结评估中的应用
王红燕1, 靳晓娜1, 姜玉新1,(), 朱朝晖1, 徐颖1, 朱庆莉1, 戴晴1, 李建初1, 李方1   
  1. 1. 100730 中国医学科学院 北京协和医学院 北京协和医院超声医学科
  • 收稿日期:2017-01-01 出版日期:2017-10-01
  • 通信作者: 姜玉新
  • 基金资助:
    国家自然科学基金(81601517,81371557)

Comparison of ultrasound and position emission tomography / computerized tomography in diagnosis and lymph node staging of breast cancer

Hongyan Wang1, Xiaona Jin1, Yuxin Jiang1,(), Zhaohui Zhu1, Ying Xu1, Qingli Zhu1, Qing Dai1, Jianchu Li1, Fang Li1   

  1. 1. Department of Diagnostic Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
  • Received:2017-01-01 Published:2017-10-01
  • Corresponding author: Yuxin Jiang
  • About author:
    Corresponding author: Jiang Yuxin, Email:
引用本文:

王红燕, 靳晓娜, 姜玉新, 朱朝晖, 徐颖, 朱庆莉, 戴晴, 李建初, 李方. 超声与正电子发射型计算机断层成像技术在乳腺癌诊断及淋巴结评估中的应用[J/OL]. 中华医学超声杂志(电子版), 2017, 14(10): 743-748.

Hongyan Wang, Xiaona Jin, Yuxin Jiang, Zhaohui Zhu, Ying Xu, Qingli Zhu, Qing Dai, Jianchu Li, Fang Li. Comparison of ultrasound and position emission tomography / computerized tomography in diagnosis and lymph node staging of breast cancer[J/OL]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2017, 14(10): 743-748.

目的

比较超声与正电子发射型计算机断层成像(PET/CT)技术在乳腺癌早期诊断中的应用价值。

方法

选取2014年2月至12月在北京协和医院行乳腺病变切除活检术的患者38例,共40个病灶,分别行超声及PET/CT检查,以病理诊断为"金标准"分别统计自动乳腺全容积成像系统(ABVS)及PET/CT的敏感度、特异度、准确性、假阳性、假阴性、阳性及阴性预测值。

结果

超声对乳腺癌诊断的敏感度95.65%、特异度70.59%、准确性85.00%;PET/CT技术对乳腺癌诊断的敏感度86.96%、特异度82.35 %、准确性85.00 %;两者联合应用的诊断敏感度86.96%、特异度94.12%、准确性90.00%。10例乳腺癌淋巴结转移的患者中,PET/CT技术对转移淋巴结诊断的敏感度、特异度及准确性分别为90.0%、92.8%、92.1%,超声对转移淋巴结诊断的敏感度、特异度及准确性分别为70.0%、96.4 %、89.5%。

结论

超声与PET/CT检查对乳腺癌的诊断均为有效的方法。两者联合应用可显著提高诊断的特异度与准确性。PET/CT对淋巴结转移灶敏感度较高,有利于临床分期,对临床治疗方案的选择及患者的预后有重要意义。

Objective

To compare the application of ultrasound and positron emission tomography/computed tomography (PET/CT) in diagnosis and lymph node staging of breast cancer.

Methods

Using automated breast volume scanner (ABVS) and PET/CT examination of 40 lesions in 38 patients, and for comparison with the pathological findings, the diagnostic accuracy of PET/CT and ABVS in breast cancer was comparatively analyzed.

Results

The sensitivity of ABVS in the diagnosis of breast cancer was 95.65%, the specificity was 70.59%, and the accuracy rate was 85.00%; the sensitivity of PET/CT in the diagnosis of breast cancer was 86.96%, the specificity was 82.35%, and the accuracy rate was 85.00%; the diagnostic sensitivity of their combined application was 86.96%, the specificity was 94.12%, and the accuracy rate was 90.00%. In 10 cases of breast cancer patients with lymph node metastasis, the sensitivity、specificity and accuracy rate of PET/CT in the diagnosis of metastatic lymph nodes were 90.0%, 92.8%, and 92.1% respectively; the sensitivity, specificity and accuracy rate of ultrasound in the diagnosis of metastatic lymph nodes were 70.0%, 96.4% and 89.5%, respectively.

Conclusions

The ABVS and PET/CT are both effective approaches in the diagnosis of breast cancer. Their combined application may significantly improve the specificity and accuracy of diagnosis. For patients with lymph node metastases, the sensitivity of PET/CT for lymph node metastases was high and conducive to clinical staging, which is an important implication in guiding the choice of clinical treatment and prognosis of patients.

表1 PET/CT及ABVS对乳腺癌原发灶的诊断价值(%)
图3,4 患者女,63岁,病理为右乳浸润性导管癌(低分化),无淋巴结转移。图3为ABVS右乳外上9~10点见低回声区,大小约2.5 cm,形态不规则,边界不清,回声尚均,超声诊断BI-RADS 5;图4为PET-CT右乳外上象限见一形态不规则且密度欠均匀病灶(箭头所示),大小约2.6 cm,放射性摄取不均匀增高,SUVmax:4.8,病灶内部见放射性减低区
图5 患者女,67岁,病理证实为左乳腺浸润性导管癌。PET-CT示:左乳巨大代谢增高灶,大小,SUV。双侧腋下、纵膈多发肿大淋巴结,代谢明显增高,双侧肋骨、多个脊椎、骨盆多发骨质破坏,代谢增高,均考虑转移灶
[1]
于鹏,王瑞民,徐白萱, 等. 超声乳腺影像报告和数据系统与18F-FDG PET/CT在乳腺疾病诊断中的相关性及联合应用价值 [J]. 中国医学影像学杂志, 2014, (10):730-734.
[2]
朱朝晖. PET /CT在肿瘤学中的应用. 现代仪器 [J]. 2006, (4):16-18.
[3]
Liberman L, Menell JH. Breast imaging reporting and data system (BI-RADS) [J]. Radiol Clin North Am, 2002, 40(3):409-430.
[4]
Greco M, Crippa F, Agresti R, et a1. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management [J]. J Natl Cancer Inst, 2001, 93(8):630-635.
[5]
Kelly KM, Dean J, Comulada WS, et al. Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts [J]. Eur Radiol, 2010, 20(3):734-742.
[6]
Watermann DO, Foldi M, Hanjalic-Beck A, et al. Three-dimensional ultrasound for the assessment of breast lesions [J]. Ultrasound Obstet Gynecol, 2005, 25(6):592-598.
[7]
Lin X, Wang J, Han F, et al. Analysis of eighty-one cases with breast lesions using automated breast volume scanner and comparison with handheld ultrasound [J]. Eur J Radiol, 2011, doi:10.1016/j.ejrad.2011.02.038
[8]
Wöhrle NK, Hellerhof K, Notohamiprodjo M, et al. Automated breast volume scanner (ABVS). A new approach for breast imaging [J]. Der Onkologe, 2011, doi:10.1007/s00761-011-2040-x [in German].
[9]
Richter K, Heywang-Kobrunner SH, Winzer KJ, et al. Detection of malignant and benign breast lesions with an automated US system: results in 120 cases [J]. Radiology, 1997, 205:823-830.
[10]
Chou YH, Tiu CM, Chen J, et al. Automated full-field breast ultrasonography: the past and the present [J]. J Med Ultrasound, 2007, 15(1):31-44.
[11]
Avril N, Dose J, Jänicke F, et al. Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose [J]. J Clin Oncol, 1996, 14(6):1848-1857.
[12]
Crowe JP Jr, Adler LP, Shenk RR, et al. Positron emission tomography and breast masses: com parison with clinical mammographic, and pathological findings [J]. Ann Surg Oncol, 1994, 1(2):132-140.
[13]
Scheidhauer K, Scharl A, Pietrzyk U, et al. Qualitative 18F-FDG positron emission tomography in primary breast cancer: clinical relevance and practicability [J]. Eur J Nucl Med, 1996, 23(6):618-623.
[14]
Tse NY, Hoh CK, Hawkins RA, et al. The application of positron emission tomograpic imaging with fluorodeoxyglucose to the evaluat on of breast disease [J]. Ann Surg, 1992, 216(1):27-34.
[15]
Buck A, Schirrmeister H, Khn T, et al. FDG uptake in breast cancer: correlation with biologica l and clinical prognostic parameters [J]. Eur J Nucl Med Mol Imaging, 2002, 29(10):1317-1323.
[16]
Heusner TA, Kuemmel S, Hahn S, et al. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients [J]. Eur J Nucl Med Mol Imaging, 2009, 36(10):1543-1550.
[17]
Inokuchi M, Furukawa H, Kayahara M,et al. The role of 18FDG PET-CT for the initial staging and therapy in primary breast cancer [J]. Gan To Kagaku Ryoho, 2009, 36(13):2526-2531.
[18]
Peare R, Staff RT, Heys SD. The use of FDG-PET in assessing axillary lymph node status in breast cancer: A systematic review and meta-analysis of the literature [J]. Breast Cancer Res Treat, 2010, 123(1):281-290.
[19]
Kim J, Lee J, Chang E, et al. Selective sentinel node plus additional non-sentinel node biopsy based on an FDG-PET/CT scan in early breast cancer patients: Single institutional experience [J]. World J Surg, 2009, 33(5):943.
[20]
Choi YJ, Shin YD, Kang YH, et al. The Effects of Preoperative 18F-FDG PET/CT in Breast Cancer Patients in Comparison to the Conventional Imaging Study [J]. J Breast Cancer, 2012, 15(4):441-448.
[21]
Mahner S, Schirrmacher S, Brenner W, et al. Comparison between positron emission tomography using 2-[fluorine-18] fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer [J]. Ann Oncol, 2008, 19(7):1249-1254.
[1] 章建全, 程杰, 陈红琼, 闫磊. 采用ACR-TIRADS评估甲状腺消融区的调查研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 966-971.
[2] 罗辉, 方晔. 品管圈在提高甲状腺结节细针穿刺检出率中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 972-977.
[3] 杨忠, 时敬业, 邓学东, 姜纬, 殷林亮, 潘琦, 梁泓, 马建芳, 王珍奇, 张俊, 董姗姗. 产前超声在胎儿22q11.2 微缺失综合征中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 852-858.
[4] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[5] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[6] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[7] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[8] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[9] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[10] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[13] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[14] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[15] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
阅读次数
全文


摘要